JP2000500125A5 - - Google Patents

Download PDF

Info

Publication number
JP2000500125A5
JP2000500125A5 JP1997517917A JP51791797A JP2000500125A5 JP 2000500125 A5 JP2000500125 A5 JP 2000500125A5 JP 1997517917 A JP1997517917 A JP 1997517917A JP 51791797 A JP51791797 A JP 51791797A JP 2000500125 A5 JP2000500125 A5 JP 2000500125A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997517917A
Other languages
English (en)
Japanese (ja)
Other versions
JP4263240B2 (ja
JP2000500125A (ja
Filing date
Publication date
Priority claimed from FR9513252A external-priority patent/FR2741069B1/fr
Priority claimed from FR9513253A external-priority patent/FR2741070B1/fr
Priority claimed from FR9602663A external-priority patent/FR2745574B1/fr
Application filed filed Critical
Priority claimed from PCT/FR1996/001730 external-priority patent/WO1997017345A1/fr
Publication of JP2000500125A publication Critical patent/JP2000500125A/ja
Publication of JP2000500125A5 publication Critical patent/JP2000500125A5/ja
Application granted granted Critical
Publication of JP4263240B2 publication Critical patent/JP4263240B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP51791797A 1995-11-09 1996-11-05 5−フェニル−3−(ピペリジン−4−イル)−1,3,4−オキサジアゾール−2(3h)−オン誘導体、及びその5−ht4又はh3レセプターリガンドとしての用途 Expired - Fee Related JP4263240B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
FR9513252A FR2741069B1 (fr) 1995-11-09 1995-11-09 Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h) -one, leur preparation et leur application en therapeutique
FR9513253A FR2741070B1 (fr) 1995-11-09 1995-11-09 Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h) -one, leur preparation et leur application en therapeutique
FR95/13252 1996-03-04
FR9602663A FR2745574B1 (fr) 1996-03-04 1996-03-04 Derives de 5-phenyl-3-(piperidin-4-yl)-1, 3, 4-oxadiazol-2 (3h)-one, leur preparation et leur application en therapeutique
FR96/02663 1996-03-04
FR95/13253 1996-03-04
PCT/FR1996/001730 WO1997017345A1 (fr) 1995-11-09 1996-11-05 Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one, utiles comme ligands des recepteurs 5-ht4 ou h¿3?

Publications (3)

Publication Number Publication Date
JP2000500125A JP2000500125A (ja) 2000-01-11
JP2000500125A5 true JP2000500125A5 (cg-RX-API-DMAC10.html) 2004-10-21
JP4263240B2 JP4263240B2 (ja) 2009-05-13

Family

ID=27253120

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51791797A Expired - Fee Related JP4263240B2 (ja) 1995-11-09 1996-11-05 5−フェニル−3−(ピペリジン−4−イル)−1,3,4−オキサジアゾール−2(3h)−オン誘導体、及びその5−ht4又はh3レセプターリガンドとしての用途

Country Status (29)

Country Link
US (1) US5929089A (cg-RX-API-DMAC10.html)
EP (1) EP0863897B1 (cg-RX-API-DMAC10.html)
JP (1) JP4263240B2 (cg-RX-API-DMAC10.html)
CN (1) CN1077891C (cg-RX-API-DMAC10.html)
AR (1) AR004708A1 (cg-RX-API-DMAC10.html)
AT (1) ATE181328T1 (cg-RX-API-DMAC10.html)
AU (1) AU707325B2 (cg-RX-API-DMAC10.html)
BG (1) BG63463B1 (cg-RX-API-DMAC10.html)
BR (1) BR9611311A (cg-RX-API-DMAC10.html)
CA (1) CA2236357C (cg-RX-API-DMAC10.html)
CO (1) CO4770968A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ287268B6 (cg-RX-API-DMAC10.html)
DE (1) DE69602970T2 (cg-RX-API-DMAC10.html)
EE (1) EE03487B1 (cg-RX-API-DMAC10.html)
ES (1) ES2135934T3 (cg-RX-API-DMAC10.html)
GR (1) GR3030823T3 (cg-RX-API-DMAC10.html)
HU (1) HUP0001168A3 (cg-RX-API-DMAC10.html)
IL (1) IL124364A (cg-RX-API-DMAC10.html)
MX (1) MX9803696A (cg-RX-API-DMAC10.html)
NO (1) NO309606B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ321626A (cg-RX-API-DMAC10.html)
PL (1) PL186204B1 (cg-RX-API-DMAC10.html)
RU (1) RU2167160C2 (cg-RX-API-DMAC10.html)
SI (1) SI0863897T1 (cg-RX-API-DMAC10.html)
SK (1) SK282335B6 (cg-RX-API-DMAC10.html)
TR (1) TR199800827T2 (cg-RX-API-DMAC10.html)
TW (1) TW371303B (cg-RX-API-DMAC10.html)
UA (1) UA50748C2 (cg-RX-API-DMAC10.html)
WO (1) WO1997017345A1 (cg-RX-API-DMAC10.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
FR2762316B1 (fr) * 1997-04-18 1999-12-17 Sanofi Synthelabo Derives de 5-aryl-3-(8-azabicyclo[3.2.1] octan-3-yl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
WO1998050383A1 (fr) * 1997-05-06 1998-11-12 Sanofi-Synthelabo Derives de 5-phenyl-1,3,4-oxadiazol-2(3h)-one et leur utilisation comme ligands 5-ht4
FR2763068B1 (fr) 1997-05-06 1999-06-04 Synthelabo Derives de 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
GB9715816D0 (en) * 1997-07-25 1997-10-01 Black James Foundation Histamine H receptor ligands
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
ES2252978T3 (es) 1998-09-18 2006-05-16 Alcon Manufacturing Ltd. Agonistas 5ht2 serotonergicos para tratar el glaucoma.
EP1173168A2 (en) * 1999-04-28 2002-01-23 Respiratorius AB Compound for use as a medicament for treatment of disorders involving bronchocontraction
EP1185263A2 (en) * 1999-06-15 2002-03-13 Respiratorius AB Receptor agonists and antagonists
KR100819381B1 (ko) 2000-08-08 2008-04-04 오르토-맥네일 파마슈티칼, 인코퍼레이티드 비-이미다졸 아릴옥시알킬아민
US6638967B2 (en) 2000-08-08 2003-10-28 Ortho-Mcneil Phamraceutical, Inc. Thiophene of furan pyrrolidine compounds
EP1311482B1 (en) * 2000-08-08 2007-02-21 Ortho-McNeil Pharmaceutical, Inc. Non-imidazole aryloxypiperidines as h3 receptor ligands
JP2005502623A (ja) 2001-07-02 2005-01-27 ノボ ノルディスク アクティーゼルスカブ 置換ピペラジンおよびジアゼパン
US7208497B2 (en) 2001-07-02 2007-04-24 Novo Nordisk A/S Substituted piperazines and diazepanes
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
JP2005508907A (ja) * 2001-09-14 2005-04-07 ノボ ノルディスク アクティーゼルスカブ ヒスタミンh3受容体に選択的に結合する置換されたピペリジン
EP1430027B1 (en) 2001-09-14 2010-09-01 High Point Pharmaceuticals, LLC Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
US6673829B2 (en) 2001-09-14 2004-01-06 Novo Nordisk A/S Aminoazetidine,-pyrrolidine and -piperidine derivatives
JP4563675B2 (ja) 2001-10-12 2010-10-13 ハイ・ポイント・ファーマスーティカルズ、エルエルシー 置換ピペリジン類、およびヒスタミンh3受容体関連疾患の治療のためのその使用
US7064135B2 (en) 2001-10-12 2006-06-20 Novo Nordisk Inc. Substituted piperidines
EP1461030A4 (en) 2001-12-14 2005-06-01 Alcon Inc AMINOALKYL-BENZOFURAN-5-OL COMPOUNDS FOR THE TREATMENT OF GLAUCOMA
US20030236259A1 (en) * 2002-02-05 2003-12-25 Rolf Hohlweg Novel aryl- and heteroarylpiperazines
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
US7332508B2 (en) * 2002-12-18 2008-02-19 Novo Nordisk A/S Substituted homopiperidine, piperidine or pyrrolidine derivatives
GB0325956D0 (en) * 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
KR100875558B1 (ko) 2004-06-15 2008-12-23 화이자 인코포레이티드 벤즈이미다졸론 카복실산 유도체
KR101286569B1 (ko) 2005-07-04 2013-07-23 하이 포인트 파마슈티칼스, 엘엘씨 신규 약제
PT1959951E (pt) * 2005-12-01 2010-03-02 Hoffmann La Roche Derivados de piperidina substituídos com heteroarilo, como inibidores de pct1-f
CN102295606A (zh) 2006-05-29 2011-12-28 高点制药有限责任公司 合成3-(1,3-苯并间二氧杂环戊烯-5-基)-6-(4-环丙基哌嗪-1-基)-哒嗪的方法及其适用的中间体
EP2014656A3 (en) 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
KR101551481B1 (ko) 2011-09-19 2015-09-08 수벤 라이프 사이언시스 리미티드 5-ηt4 수용체 리간드인 헤테로아릴 화합물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055476A (en) * 1990-08-13 1991-10-08 Hoechst-Roussel Pharmaceuticals Incorporated 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives
CA2116024A1 (en) * 1991-08-20 1993-03-04 Francis David King 5-ht4 receptor antagonists
SG49153A1 (en) * 1991-09-12 1998-05-18 Smithkline Beecham Plc 5-HT4 receptor antagonists
NZ246915A (en) * 1992-02-06 1996-05-28 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives, preparation and pharmaceutical compositions thereof
GB9219163D0 (en) * 1992-09-10 1992-10-28 Smithkline Beecham Plc Pharmaceuticals
JPH06157518A (ja) * 1992-11-27 1994-06-03 Yamanouchi Pharmaceut Co Ltd 新規なオキサジアゾール誘導体又はその塩

Similar Documents

Publication Publication Date Title
JP2000500228A5 (cg-RX-API-DMAC10.html)
JP2000500445A5 (cg-RX-API-DMAC10.html)
JP2000500440A5 (cg-RX-API-DMAC10.html)
JP2000500327A5 (cg-RX-API-DMAC10.html)
JP2000500145A5 (cg-RX-API-DMAC10.html)
JP2000500155A5 (cg-RX-API-DMAC10.html)
JP2000500406A5 (cg-RX-API-DMAC10.html)
JP2000500361A5 (cg-RX-API-DMAC10.html)
JP2000500115A5 (cg-RX-API-DMAC10.html)
JP2000500322A5 (cg-RX-API-DMAC10.html)
JP2000500258A5 (cg-RX-API-DMAC10.html)
JP2000500342A5 (cg-RX-API-DMAC10.html)
JP2000500192A5 (cg-RX-API-DMAC10.html)
JP2000500112A5 (cg-RX-API-DMAC10.html)
JP2000500226A5 (cg-RX-API-DMAC10.html)
JP2000500051A5 (cg-RX-API-DMAC10.html)
JP2000500407A5 (cg-RX-API-DMAC10.html)
JP2000500397A5 (cg-RX-API-DMAC10.html)
JP2000500166A5 (cg-RX-API-DMAC10.html)
JP2000500125A5 (cg-RX-API-DMAC10.html)
JP2000500346A5 (cg-RX-API-DMAC10.html)
JP2000500090A5 (cg-RX-API-DMAC10.html)
JP2000500257A5 (cg-RX-API-DMAC10.html)
JP2000500429A5 (cg-RX-API-DMAC10.html)
JPH11508549A5 (cg-RX-API-DMAC10.html)